Search - tctmd.com

Displaying 861 - 880 of 2151

Sort: Relevancy | Date

News Daily News

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

L.A. McKeown

May 13, 2019

News Daily News

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

L.A. McKeown

May 07, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Daily News

Low-Level Ionizing Radiation May Raise Hypertension Risk

L.A. McKeown

May 03, 2019

News Daily News

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

L.A. McKeown

April 30, 2019

News Daily News

Two Pediatric Cardiac Catheters Recalled for Defective Balloons

L.A. McKeown

April 26, 2019

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

L.A. McKeown

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Initiative Helps Low-Resource Chinese Hospitals Provide Better ACS Care

L.A. McKeown

April 17, 2019

News Daily News

Less Not Always More When Medicating Frail, Elderly Acute MI Patients

L.A. McKeown

April 16, 2019

News Daily News

New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings

L.A. McKeown

April 15, 2019

News Daily News

High-Normal Glucose Challenge Tests in Pregnancy May Predict Future Risk of CV Events

L.A. McKeown

April 11, 2019

News Daily News

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

L.A. McKeown

April 09, 2019

News Daily News

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

L.A. McKeown

April 04, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

L.A. McKeown

April 02, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

L.A. McKeown

March 27, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

Advertisement

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Low-Level Ionizing Radiation May Raise Hypertension Risk

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

Two Pediatric Cardiac Catheters Recalled for Defective Balloons

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Initiative Helps Low-Resource Chinese Hospitals Provide Better ACS Care

Less Not Always More When Medicating Frail, Elderly Acute MI Patients

New Added Sugar Labeling Could Cut CVD, Spur $31 Billion in Healthcare Savings

High-Normal Glucose Challenge Tests in Pregnancy May Predict Future Risk of CV Events

Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Myocardial Injury Often Miscoded as Type 2 MI

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content